VCNX - バクシネックス (Vaccinex Inc.)

VCNXのニュース

   Thinking about buying stock in Barnes & Noble Education, Vaccinex Inc, Seelos Therapeutics, PDS Biotechnology, or SINTX Technologies?  2020/07/17 13:31:00 PR Newswire
NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNED, VCNX, SEEL, PDSB, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  2020/05/14 14:05:02 Zacks Investment Research
Vaccinex Inc (VCNX) delivered earnings and revenue surprises of 8.16% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  2020/05/13 16:30:22 Zacks Investment Research
Vaccinex Inc (VCNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO  2020/05/01 11:54:30 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) AstraZeneca plc (NYSE: AZN ) (announced an agreement with the University of Oxford for the development of the latter's potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2) BIO-TECHNE Corp (NASDAQ: TECH ) (reacted to its quarterly results) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Catalent Inc (NYSE: CTLT ) ChemoCentryx Inc (NASDAQ: CCXI ) DexCom, Inc. (NASDAQ: DXCM ) Imara Inc (NASDAQ: IMRA ) Replimune Group Inc (NASDAQ: REPL ) Down In The Dumps (Biotech stocks that hit 52-week lows May 1.) Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Vaccinex Inc (NASDAQ: VCNX ) Stocks In Focus Bio-Rad's Serology Test Gets EUA From FDA For Novel Coronavirus Test Bio-Rad said the FDA granted Emergency Use Authorization for its SARS-CoV-2 Total Ab test, making it the first total antibody test to receive EUA from the FDA.
   The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant  2020/04/16 12:09:13 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) C alithera Biosciences Inc (NASDAQ: CALA ) (provided an update on the impact of COVID-19 on its ongoing clinical trials) Eli Lilly And Co (NYSE: LLY ) Keros Therapeutics Inc (NASDAQ: KROS ) (went public April 8) Masimo Corporation (NASDAQ: MASI ) Moderna Inc (NASDAQ: MRNA (analysts hiked price targets for the shares following the company's Virtual Vaccines Day) Pluristem Therapeutics Inc. (NASDAQ: PSTI ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows April 15.) Akorn, Inc. (NASDAQ: AKRX ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) TherapeuticsMD Inc (NASDAQ: TXMD ) Vaccinex Inc (NASDAQ: VCNX ) Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter .
   Thinking about buying stock in Barnes & Noble Education, Vaccinex Inc, Seelos Therapeutics, PDS Biotechnology, or SINTX Technologies?  2020/07/17 13:31:00 PR Newswire
NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNED, VCNX, SEEL, PDSB, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  2020/05/14 14:05:02 Zacks Investment Research
Vaccinex Inc (VCNX) delivered earnings and revenue surprises of 8.16% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  2020/05/13 16:30:22 Zacks Investment Research
Vaccinex Inc (VCNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO  2020/05/01 11:54:30 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) AstraZeneca plc (NYSE: AZN ) (announced an agreement with the University of Oxford for the development of the latter's potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2) BIO-TECHNE Corp (NASDAQ: TECH ) (reacted to its quarterly results) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Catalent Inc (NYSE: CTLT ) ChemoCentryx Inc (NASDAQ: CCXI ) DexCom, Inc. (NASDAQ: DXCM ) Imara Inc (NASDAQ: IMRA ) Replimune Group Inc (NASDAQ: REPL ) Down In The Dumps (Biotech stocks that hit 52-week lows May 1.) Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Vaccinex Inc (NASDAQ: VCNX ) Stocks In Focus Bio-Rad's Serology Test Gets EUA From FDA For Novel Coronavirus Test Bio-Rad said the FDA granted Emergency Use Authorization for its SARS-CoV-2 Total Ab test, making it the first total antibody test to receive EUA from the FDA.
   The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant  2020/04/16 12:09:13 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) C alithera Biosciences Inc (NASDAQ: CALA ) (provided an update on the impact of COVID-19 on its ongoing clinical trials) Eli Lilly And Co (NYSE: LLY ) Keros Therapeutics Inc (NASDAQ: KROS ) (went public April 8) Masimo Corporation (NASDAQ: MASI ) Moderna Inc (NASDAQ: MRNA (analysts hiked price targets for the shares following the company's Virtual Vaccines Day) Pluristem Therapeutics Inc. (NASDAQ: PSTI ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows April 15.) Akorn, Inc. (NASDAQ: AKRX ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) TherapeuticsMD Inc (NASDAQ: TXMD ) Vaccinex Inc (NASDAQ: VCNX ) Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter .
   Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  2020/05/14 14:05:02 Zacks Investment Research
Vaccinex Inc (VCNX) delivered earnings and revenue surprises of 8.16% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  2020/05/13 16:30:22 Zacks Investment Research
Vaccinex Inc (VCNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO  2020/05/01 11:54:30 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) AstraZeneca plc (NYSE: AZN ) (announced an agreement with the University of Oxford for the development of the latter's potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2) BIO-TECHNE Corp (NASDAQ: TECH ) (reacted to its quarterly results) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Catalent Inc (NYSE: CTLT ) ChemoCentryx Inc (NASDAQ: CCXI ) DexCom, Inc. (NASDAQ: DXCM ) Imara Inc (NASDAQ: IMRA ) Replimune Group Inc (NASDAQ: REPL ) Down In The Dumps (Biotech stocks that hit 52-week lows May 1.) Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Vaccinex Inc (NASDAQ: VCNX ) Stocks In Focus Bio-Rad's Serology Test Gets EUA From FDA For Novel Coronavirus Test Bio-Rad said the FDA granted Emergency Use Authorization for its SARS-CoV-2 Total Ab test, making it the first total antibody test to receive EUA from the FDA.
   The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant  2020/04/16 12:09:13 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) C alithera Biosciences Inc (NASDAQ: CALA ) (provided an update on the impact of COVID-19 on its ongoing clinical trials) Eli Lilly And Co (NYSE: LLY ) Keros Therapeutics Inc (NASDAQ: KROS ) (went public April 8) Masimo Corporation (NASDAQ: MASI ) Moderna Inc (NASDAQ: MRNA (analysts hiked price targets for the shares following the company's Virtual Vaccines Day) Pluristem Therapeutics Inc. (NASDAQ: PSTI ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows April 15.) Akorn, Inc. (NASDAQ: AKRX ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) TherapeuticsMD Inc (NASDAQ: TXMD ) Vaccinex Inc (NASDAQ: VCNX ) Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter .
   The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO  2020/04/03 11:36:23 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BELLUS Health Inc (NASDAQ: BLU ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows April 2) BIOLASE Inc (NASDAQ: BIOL ) BioNano Genomics Inc (NASDAQ: BNGO ) (priced $18 million common stock and warrant offering) Celcuity Inc (NASDAQ: CELC ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) Mediwound Ltd (NASDAQ: MDWD ) Merus NV (NASDAQ: MRUS ) Myokardia Inc (NASDAQ: MYOK ) Neovasc Inc (NASDAQ: NVCN ) Opko Health Inc. (NASDAQ: OPK ) PDS Biotechnology Corp (NASDAQ: PDSB ) Phio Pharmaceuticals Corp (NASDAQ: PHIO ) Precipio Inc (NASDAQ: PRPO ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Chanticleer Holdings Common Stock (NASDAQ: SONN ) Vaccinex Inc (NASDAQ: VCNX ) Stocks In Focus Fate Announces CAR T-cell Therapy Licensing Deal With J&J's Janssen Unit Fate Therapeutics Inc (NASDAQ: FATE ) said it has entered into a global collaboration and option agreement with Johnson & Johnson (NYSE: JNJ )'s Janssen unit, under which it will apply its iPSC product platform to research and preclinically develop new iPSC-derived chimeric antigen receptor, or CAR, NK and CAR T-cell product candidates.

calendar